0001209191-16-125860.txt : 20160603
0001209191-16-125860.hdr.sgml : 20160603
20160603210027
ACCESSION NUMBER: 0001209191-16-125860
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160603
DATE AS OF CHANGE: 20160603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bell Graeme
CENTRAL INDEX KEY: 0001643757
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 161697330
MAIL ADDRESS:
STREET 1: 1324 WAVERLY ROAD
CITY: GLADWYNE
STATE: PA
ZIP: 19035
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-01
0
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001643757
Bell Graeme
C/O ANACOR PHARMACEUTICALS, INC.
1020 EAST MEADOW CIRCLE
PALO ALTO
CA
94303
0
1
0
0
Executive VP and CFO
Common Stock
2016-06-01
4
S
0
751
99.28
D
10255
D
This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
/s/ John C. Duncanson, as attorney-in-fact
2016-06-03